Population pharmacokinetics of everolimus in renal transplant recipients receiving long-term multiple immunosuppressive therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population pharmacokinetics of everolimus in renal transplant recipients receiving long-term multiple immunosuppressive therapy

Published:2024-06 Issue: Volume:56 Page:101009
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Sakaue Tomoyuki^ORCID,Yamamoto Kazuhiro^ORCID,Itohara Kotaro^ORCID,Kitahiro Yumi,Endo Takahito,Yokoyama Naoki,Ishimura Takeshi,Omura Tomohiro^ORCID,Yano Ikuko^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Reference32 articles.

1. Everolimus with reduced calcineurin inhibitor exposure in renal transplantation;Pascual;J Am Soc Nephrol,2018

2. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summary

3. Therapeutic drug monitoring of everolimus: a consensus report;Shipkova;Ther Drug Monit,2016

4. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin;Crowe;Pharm Res (N Y),1998

5. Population pharmacokinetics and pharmacogenetics of everolimus in renal transplant patients;Moes;Clin Pharmacokinet,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP